Option Care Health (NASDAQ:OPCH) Releases Q4 2024 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.420-0.450 for the period, compared to the consensus estimate of 0.330. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Finally, Barrington Research reduced their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $29.14.

Option Care Health Price Performance

NASDAQ OPCH traded up $2.36 during mid-day trading on Monday, hitting $26.35. The stock had a trading volume of 605,179 shares, compared to its average volume of 1,321,693. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm’s 50 day moving average is $23.10 and its 200 day moving average is $27.69. The stock has a market capitalization of $4.48 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 2.43 and a beta of 1.31. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.63.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.